Abhishek Keraliya, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intestinal Perforation | 1 | 2022 | 249 | 0.700 |
Why?
|
Molecular Targeted Therapy | 5 | 2019 | 2812 | 0.650 |
Why?
|
Solitary Fibrous Tumors | 2 | 2016 | 67 | 0.630 |
Why?
|
Heart Neoplasms | 2 | 2021 | 362 | 0.550 |
Why?
|
Diagnostic Imaging | 5 | 2016 | 3527 | 0.520 |
Why?
|
Coronary Artery Disease | 6 | 2019 | 6403 | 0.520 |
Why?
|
Tomography, X-Ray Computed | 17 | 2022 | 20556 | 0.510 |
Why?
|
Coronary Angiography | 5 | 2017 | 4470 | 0.460 |
Why?
|
Facial Nerve Diseases | 1 | 2014 | 49 | 0.460 |
Why?
|
Arteritis | 1 | 2016 | 158 | 0.450 |
Why?
|
Hematologic Neoplasms | 2 | 2016 | 1896 | 0.440 |
Why?
|
Epidermal Cyst | 1 | 2014 | 64 | 0.430 |
Why?
|
Facial Asymmetry | 1 | 2014 | 172 | 0.430 |
Why?
|
Cranial Nerve Diseases | 1 | 2014 | 111 | 0.430 |
Why?
|
Pineal Gland | 1 | 2014 | 158 | 0.420 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2013 | 49 | 0.420 |
Why?
|
Trigeminal Neuralgia | 1 | 2014 | 107 | 0.420 |
Why?
|
Embolism | 1 | 2016 | 399 | 0.410 |
Why?
|
Facial Pain | 1 | 2013 | 120 | 0.410 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2013 | 134 | 0.410 |
Why?
|
Trigeminal Nerve | 1 | 2014 | 248 | 0.400 |
Why?
|
Edema | 1 | 2015 | 765 | 0.380 |
Why?
|
Coronary Vessels | 3 | 2017 | 3095 | 0.360 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2016 | 594 | 0.360 |
Why?
|
Facial Paralysis | 1 | 2014 | 346 | 0.350 |
Why?
|
Aortic Diseases | 1 | 2016 | 735 | 0.340 |
Why?
|
Aorta | 1 | 2016 | 2041 | 0.300 |
Why?
|
Magnetic Resonance Imaging | 14 | 2021 | 36402 | 0.300 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 915 | 0.280 |
Why?
|
Brain Diseases | 1 | 2014 | 1545 | 0.240 |
Why?
|
Tomography Scanners, X-Ray Computed | 2 | 2016 | 173 | 0.230 |
Why?
|
Positron-Emission Tomography | 5 | 2017 | 6483 | 0.230 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4533 | 0.230 |
Why?
|
Hyperostosis, Diffuse Idiopathic Skeletal | 2 | 2020 | 23 | 0.220 |
Why?
|
Autoimmune Diseases | 1 | 2016 | 2238 | 0.220 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2527 | 0.220 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2024 | 117 | 0.220 |
Why?
|
Spinal Fractures | 2 | 2020 | 704 | 0.210 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6925 | 0.200 |
Why?
|
Spondylitis, Ankylosing | 2 | 2020 | 155 | 0.200 |
Why?
|
Thrombosis | 1 | 2016 | 2943 | 0.200 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2533 | 0.190 |
Why?
|
Spinal Injuries | 2 | 2021 | 300 | 0.180 |
Why?
|
Carcinoma, Renal Cell | 1 | 2015 | 3164 | 0.180 |
Why?
|
Iodine | 1 | 2022 | 287 | 0.170 |
Why?
|
Adenocarcinoma | 2 | 2016 | 6340 | 0.170 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 2019 | 31 | 0.160 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4250 | 0.160 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2020 | 200 | 0.140 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5672 | 0.140 |
Why?
|
Humans | 43 | 2024 | 760617 | 0.130 |
Why?
|
Sarcoidosis | 1 | 2021 | 521 | 0.130 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13635 | 0.130 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2017 | 261 | 0.120 |
Why?
|
Thyroglossal Cyst | 1 | 2015 | 31 | 0.120 |
Why?
|
Wounds, Nonpenetrating | 1 | 2021 | 806 | 0.120 |
Why?
|
Testicular Neoplasms | 1 | 2021 | 800 | 0.120 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11459 | 0.120 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2016 | 77 | 0.120 |
Why?
|
Fibromatosis, Aggressive | 1 | 2016 | 126 | 0.120 |
Why?
|
Mastocytosis | 1 | 2017 | 150 | 0.120 |
Why?
|
Thoracic Neoplasms | 1 | 2016 | 267 | 0.120 |
Why?
|
Aortography | 1 | 2016 | 421 | 0.110 |
Why?
|
Colonoscopy | 1 | 2022 | 1396 | 0.110 |
Why?
|
Coronary Vessel Anomalies | 1 | 2017 | 307 | 0.110 |
Why?
|
Physician's Role | 1 | 2020 | 917 | 0.110 |
Why?
|
Ascites | 1 | 2015 | 338 | 0.110 |
Why?
|
Cerebrospinal Fluid | 1 | 2016 | 544 | 0.110 |
Why?
|
Pericardial Effusion | 1 | 2015 | 247 | 0.110 |
Why?
|
Radiation Dosage | 2 | 2020 | 1956 | 0.100 |
Why?
|
Coronary Aneurysm | 1 | 2015 | 232 | 0.100 |
Why?
|
Pleural Effusion | 1 | 2015 | 341 | 0.100 |
Why?
|
Thyroid Neoplasms | 2 | 2016 | 2332 | 0.100 |
Why?
|
Coronary Thrombosis | 1 | 2015 | 440 | 0.100 |
Why?
|
Lymphoma | 1 | 2021 | 1899 | 0.100 |
Why?
|
Spine | 1 | 2019 | 1112 | 0.100 |
Why?
|
Coronary Occlusion | 1 | 2015 | 304 | 0.100 |
Why?
|
Male | 22 | 2024 | 360358 | 0.100 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2017 | 575 | 0.100 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1241 | 0.090 |
Why?
|
Genital Neoplasms, Female | 1 | 2016 | 532 | 0.090 |
Why?
|
Coronary Stenosis | 1 | 2017 | 794 | 0.090 |
Why?
|
Anticholesteremic Agents | 1 | 2017 | 967 | 0.080 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 785 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2021 | 1948 | 0.080 |
Why?
|
Mitral Valve | 1 | 2017 | 1464 | 0.080 |
Why?
|
Fractures, Bone | 1 | 2021 | 2044 | 0.080 |
Why?
|
Atrophy | 1 | 2014 | 1631 | 0.080 |
Why?
|
Bone and Bones | 2 | 2017 | 2565 | 0.080 |
Why?
|
Leukemia | 1 | 2016 | 1520 | 0.080 |
Why?
|
Mitral Valve Insufficiency | 1 | 2017 | 1400 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2491 | 0.070 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2017 | 1553 | 0.070 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7389 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6305 | 0.070 |
Why?
|
Coronary Artery Bypass | 1 | 2016 | 2188 | 0.070 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 1405 | 0.070 |
Why?
|
Huntington Disease | 1 | 2013 | 1144 | 0.070 |
Why?
|
Neoplasms | 1 | 2015 | 22131 | 0.070 |
Why?
|
Female | 18 | 2024 | 392148 | 0.070 |
Why?
|
Mass Screening | 1 | 2022 | 5424 | 0.070 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2014 | 1372 | 0.070 |
Why?
|
Myocardial Ischemia | 1 | 2017 | 2110 | 0.070 |
Why?
|
Prostate-Specific Antigen | 1 | 2016 | 2465 | 0.070 |
Why?
|
Sarcoma | 1 | 2016 | 1800 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3680 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15251 | 0.060 |
Why?
|
Adult | 10 | 2021 | 220969 | 0.060 |
Why?
|
Middle Aged | 12 | 2021 | 220584 | 0.050 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2014 | 2789 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2016 | 64568 | 0.050 |
Why?
|
Melanoma | 2 | 2019 | 5697 | 0.040 |
Why?
|
Anticoagulants | 1 | 2016 | 4785 | 0.040 |
Why?
|
Aged | 9 | 2020 | 169042 | 0.040 |
Why?
|
Whole Body Imaging | 1 | 2021 | 283 | 0.040 |
Why?
|
Brain Neoplasms | 2 | 2019 | 9026 | 0.040 |
Why?
|
Spondylosis | 1 | 2019 | 84 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9172 | 0.040 |
Why?
|
Hepatomegaly | 1 | 2017 | 84 | 0.040 |
Why?
|
Splenomegaly | 1 | 2017 | 189 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2021 | 80566 | 0.030 |
Why?
|
Trauma Centers | 1 | 2021 | 936 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2015 | 2008 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 2021 | 976 | 0.030 |
Why?
|
Preoperative Period | 1 | 2017 | 550 | 0.030 |
Why?
|
Thyroiditis | 1 | 2015 | 86 | 0.030 |
Why?
|
Death, Sudden | 1 | 2017 | 301 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 463 | 0.030 |
Why?
|
Fibrosis | 1 | 2021 | 2045 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12966 | 0.030 |
Why?
|
Boston | 2 | 2016 | 9313 | 0.030 |
Why?
|
Lymphatic Diseases | 1 | 2015 | 320 | 0.030 |
Why?
|
Hepatitis | 1 | 2015 | 228 | 0.030 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 1222 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2016 | 11106 | 0.030 |
Why?
|
Young Adult | 2 | 2016 | 59179 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2015 | 15612 | 0.030 |
Why?
|
Survival Rate | 2 | 2016 | 12719 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 2016 | 1972 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2016 | 11116 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 2014 | 1122 | 0.020 |
Why?
|
Organ Specificity | 1 | 2015 | 1964 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2606 | 0.020 |
Why?
|
World Health Organization | 1 | 2016 | 1321 | 0.020 |
Why?
|
Prevalence | 2 | 2016 | 15689 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6762 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2019 | 1275 | 0.020 |
Why?
|
Child | 2 | 2014 | 80079 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4174 | 0.020 |
Why?
|
Myocardium | 1 | 2021 | 4724 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2017 | 9277 | 0.020 |
Why?
|
Pancreatitis | 1 | 2015 | 1097 | 0.020 |
Why?
|
Contrast Media | 1 | 2020 | 5305 | 0.020 |
Why?
|
Colitis | 1 | 2015 | 1234 | 0.020 |
Why?
|
Risk Factors | 3 | 2019 | 74115 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 4910 | 0.020 |
Why?
|
Pneumonia | 1 | 2015 | 2143 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22148 | 0.010 |
Why?
|
Glucose | 1 | 2013 | 4345 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7871 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14648 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5319 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14591 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 14018 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20074 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41457 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16571 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29600 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2016 | 58894 | 0.010 |
Why?
|
Adolescent | 1 | 2016 | 88234 | 0.000 |
Why?
|